由NIH支持的临床前血液测试通过分析32种蛋白质来预测成人对像COPD这样的严重呼吸道疾病的风险。 A preclinical blood test, supported by NIH, predicts adults' risk for severe respiratory conditions like COPD by analyzing 32 proteins.
国家卫生研究所支助开发的临床前血液测试可以预测成人对慢性阻塞性肺病等严重呼吸道疾病的风险。 A preclinical blood test, developed with National Institutes of Health support, can predict adults' risk for severe respiratory conditions like chronic obstructive pulmonary disease (COPD). 通过分析32种蛋白质,根据对近2 500名美国成人进行的30年研究,测试得出了风险分数。 Analyzing 32 proteins, the test generates a risk score based on a 30-year study of nearly 2,500 U.S. adults. 虽然尚未获准临床使用,但表明有望及早发现有风险的个人,从而有可能改善肺部健康结果。 While not yet approved for clinical use, it shows promise for early identification of at-risk individuals, potentially improving lung health outcomes.